Bergmann, John E.,Cutshall, Neil S.,Demopulos, Gregory A.,Florio, Vincent A.,Gaitanaris, George,Gray, Patrick,Hohmann, John,Onrust, Rene,Zengtpg, Hongkui
申请号：
AU2013202493
公开号：
AU2013202493B2
申请日:
2013.04.04
申请国别(地区):
AU
年份:
2016
代理人:
摘要：
#$%^&*AU2013202493B220160310.pdf#####ABSTRACT A method of treating a movement abnormality associated with the pathology of a neurological movement disorder, such as Parkinson's disease or Restless Leg(s) Syndrome by administering a therapeutically effective amount of a PDE7 inhibitory agent. An aspect of the invention provides 5 for the administration of a PDE7 inhibitory agent in conjunction with a dopamine agonist or precursor, such as levodopa. In another aspect of the invention, the PDE7 inhibitory agent may be selective for PDE7 relative to other molecular targets (i) known to be involved with the pathology of Parkinson's disease or (ii) at which other drug(s) that are therapeutically effective to treat Parkinson's disease act.
